Beta Bionics, Inc. (BBNX) Current Deferred Revenue (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Current Deferred Revenue data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 79.66% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 79.66% YoY) and the FY2025 annual result came in at $1.6 million, up 65.81% from the prior year.
• Current Deferred Revenue improved to $1.7 million in Q1 2026 per BBNX's latest filing, from $1.6 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.7 million in Q1 2026, with the low at $87000.0 in Q4 2023.
• Average Current Deferred Revenue over 4 years is $1.1 million, with a median of $1.1 million recorded in 2025.
• Year-over-year, Current Deferred Revenue soared 979.31% in 2024 and jumped 65.81% in 2025.
• Beta Bionics' Current Deferred Revenue stood at $87000.0 in 2023, then soared by 979.31% to $939000.0 in 2024, then jumped by 65.81% to $1.6 million in 2025, then climbed by 9.51% to $1.7 million in 2026.
• Business Quant data shows BBNX's Current Deferred Revenue at $1.7 million in Q1 2026, $1.6 million in Q4 2025, and $1.3 million in Q3 2025.